Arkolith/Insider Trading/DRNA/Form 4

Fambrough Douglas

Chief Executive Officer, DirectorDicerna Pharmaceuticals Inc (DRNA) · full profile →Form 4 · filed Dec 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
15
1 non-derivative · 14 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2021Disposed to issuer(D)231K$38.25$8.9M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 28, 2021Disposed to issuer(D)60K——0
Dec 28, 2021Disposed to issuer(D)41K——0
Dec 28, 2021Disposed to issuer(D)191K——0
Dec 28, 2021Disposed to issuer(D)281K——0
Dec 28, 2021Disposed to issuer(D)55K——0
Dec 28, 2021Disposed to issuer(D)225K——0
Dec 28, 2021Disposed to issuer(D)255K——0
Dec 28, 2021Disposed to issuer(D)505K——0
Dec 28, 2021Disposed to issuer(D)72K——0
Dec 28, 2021Disposed to issuer(D)200K——0
Dec 28, 2021Disposed to issuer(D)200K——0
Dec 28, 2021Disposed to issuer(D)225K——0
Dec 28, 2021Disposed to issuer(D)250K——0
Dec 28, 2021Disposed to issuer(D)248K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001399529-21-000198) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML